The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.
about
Interaction between Cannabinoid System and Toll-Like Receptors Controls InflammationUp-Regulated Expression of LAMP2 and Autophagy Activity during Neuroendocrine Differentiation of Prostate Cancer LNCaP CellsCannabinoid Receptor 1 Participates in Liver Inflammation by Promoting M1 Macrophage Polarization via RhoA/NF-κB p65 and ERK1/2 Pathways, Respectively, in Mouse Liver Fibrogenesis.Effect of leukocyte inhibitory factor on neuron differentiation from human induced pluripotent stem cell-derived neural precursor cells.Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212-2 in renal cell carcinoma.
P2860
The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The cannabinoid WIN 55,212-2 p ...... f LNCaP prostate cancer cells.
@en
type
label
The cannabinoid WIN 55,212-2 p ...... f LNCaP prostate cancer cells.
@en
prefLabel
The cannabinoid WIN 55,212-2 p ...... f LNCaP prostate cancer cells.
@en
P2093
P2860
P356
P1476
The cannabinoid WIN 55,212-2 p ...... f LNCaP prostate cancer cells.
@en
P2093
A Ramos-Torres
N Rodríguez-Henche
P2860
P2888
P304
P356
10.1038/PCAN.2016.19
P577
2016-06-21T00:00:00Z
P6179
1029514530